141 related articles for article (PubMed ID: 8878504)
21. The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer.
Tartter PI; Steinberg B; Barron DM; Martinelli G
Arch Surg; 1987 Nov; 122(11):1264-8. PubMed ID: 3675190
[TBL] [Abstract][Full Text] [Related]
22. Interferon-Gamma Secretion Is Significantly Decreased in Stage III Breast Cancer Patients.
Yi JI; Schneider J; Lim ST; Park B; Suh YJ
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674146
[TBL] [Abstract][Full Text] [Related]
23. Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer.
Kuwahara Y; Kusugami K; Morise K; Shimokata K
Gastroenterol Jpn; 1987 Aug; 22(4):428-34. PubMed ID: 3117611
[TBL] [Abstract][Full Text] [Related]
24. Innate immune function after breast, lung, and colorectal cancer surgery.
Ramirez MF; Ai D; Bauer M; Vauthey JN; Gottumukkala V; Kee S; Shon D; Truty M; Kuerer HM; Kurz A; Hernandez M; Cata JP
J Surg Res; 2015 Mar; 194(1):185-93. PubMed ID: 25475022
[TBL] [Abstract][Full Text] [Related]
25. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
26. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer.
Konjević G; Spuzić I
Neoplasma; 1993; 40(2):81-5. PubMed ID: 8350959
[TBL] [Abstract][Full Text] [Related]
27. [Factors influencing depression of natural killer activity and its prevention in esophageal cancer patients].
Zeze K; Saito T; Kobayashi M
Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):22-33. PubMed ID: 2704363
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
Qiu H; Xiao-Jun W; Zhi-Wei Z; Gong C; Guo-Qiang W; Li-Yi Z; Yuan-Fang L; Rajiv-Prasad K
Hepatogastroenterology; 2009; 56(94-95):1310-5. PubMed ID: 19950782
[TBL] [Abstract][Full Text] [Related]
29. Natural killer cells over time in patients with colorectal cancer.
Orsi AJ; Tax AW; Nuamah I; Barsevick A; McCorkle R
Cancer Pract; 1996; 4(5):252-7. PubMed ID: 9004571
[TBL] [Abstract][Full Text] [Related]
30. The importance of T-lymphocyte subsets on overall survival of colorectal and gastric cancer patients.
Milasiene V; Stratilatovas E; Norkiene V
Medicina (Kaunas); 2007; 43(7):548-54. PubMed ID: 17768369
[TBL] [Abstract][Full Text] [Related]
31. Natural killer activity and serum immunosuppressive acidic protein levels in esophageal and gastric cancers.
Oka M; Mitsunaga H; Hazama S; Yoshino S; Suzuki T
Surg Today; 1993; 23(8):669-74. PubMed ID: 8400669
[TBL] [Abstract][Full Text] [Related]
32. [Functional activity of the natural killers and macrophages in patients with breast tumors].
Andrianov IG; Voronov SM; Dobkin AN; Okulov VB; Orlov AB
Vopr Onkol; 1988; 34(12):1455-60. PubMed ID: 3265236
[TBL] [Abstract][Full Text] [Related]
33. [Effect of tumor burden on differentiation of T lymphocytes in the peripheral blood of patients with colorectal cancer].
Cui M; Wang S; Ye YJ; Cui ZR; Ke Y
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):16-9. PubMed ID: 17403305
[TBL] [Abstract][Full Text] [Related]
34. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.
Matsuda M; Petersson M; Lenkei R; Taupin JL; Magnusson I; Mellstedt H; Anderson P; Kiessling R
Int J Cancer; 1995 Jun; 61(6):765-72. PubMed ID: 7790109
[TBL] [Abstract][Full Text] [Related]
35. Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-alpha and interleukin-2 on natural killer cell function against tumor cell lines.
Alvarado CS; Findley HW; Chan WC; Hnath RS; Abdel-Mageed A; Pais RC; Kutner MH; Ragab AH
Cancer; 1989 Jan; 63(1):83-9. PubMed ID: 2783377
[TBL] [Abstract][Full Text] [Related]
36. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with primary lung cancer.
Kim SK; Cho CH; Ahn CM; Jang SH; Lee YH; Kim SK; Chang J; Lee BK; Kim SJ; Youn JK
Yonsei Med J; 1992 Mar; 33(1):41-7. PubMed ID: 1502829
[TBL] [Abstract][Full Text] [Related]
37. The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.
Brenner BG; Margolese RG
Cancer; 1991 Aug; 68(3):482-8. PubMed ID: 2065267
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix.
Vaquer S; Jordá J; López de la Osa E; Alvarez de los Heros J; López-García N; Alvarez de Mon M
Gynecol Oncol; 1990 Jan; 36(1):90-2. PubMed ID: 2295458
[TBL] [Abstract][Full Text] [Related]
39. Changes in peripheral T-cell subsets and natural-killer cytotoxicity in relation to colorectal cancer surgery.
Tartter PI; Martinelli G; Steinberg B; Barron D
Cancer Detect Prev; 1986; 9(3-4):359-64. PubMed ID: 3488807
[TBL] [Abstract][Full Text] [Related]
40. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.
Jobin G; Rodriguez-Suarez R; Betito K
Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
